{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:16:02Z","timestamp":1790612162130,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"DOI":"10.7759\/cureus.69140","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T06:38:43Z","timestamp":1726036723000},"source":"Crossref","is-referenced-by-count":2,"title":["Cisplatin-Induced Toxic Optic Neuropathy in a Patient With Hodgkin\u2019s Lymphoma"],"prefix":"10.7759","author":[{"given":"See Yee","family":"Bee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemaima","family":"Che Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona A","family":"Nasaruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainal Adlin","family":"Naffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag S","year":"2018","unstructured":"Shanbhag S, Ambinder RF. Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018, 68:116-32. 10.3322\/caac.21438","journal-title":"CA Cancer J Clin"},{"key":"ref2","article-title":"DHAP chemotherapy for recurrent\/refractory lymphoma - five year follow-up of 112 patients","volume":"1161","author":"Walewski JA","year":"2001","unstructured":"Walewski JA, Romejko-Jarosinska J, Zwolinski J. DHAP chemotherapy for recurrent\/refractory lymphoma - five year follow-up of 112 patients. ASCO Abstract. 2001, 1161: 43.","journal-title":"ASCO Abstract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.3.423","article-title":"Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation","volume":"9","author":"Press OW","year":"1991","unstructured":"Press OW, Livingston R, Mortimer J, Collins C, Appelbaum F. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. J Clin Oncol. 1991, 9:423-31. 10.1200\/JCO.1991.9.3.423","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2020.10.013","article-title":"A case of oxaliplatin-related toxic optic neuropathy","volume":"44","author":"Beaumont W","year":"2021","unstructured":"Beaumont W, Sustronck P, Souied EH. A case of oxaliplatin-related toxic optic neuropathy. J Fr Ophtalmol. 2021, 44:e393-5. 10.1016\/j.jfo.2020.10.013","journal-title":"J Fr Ophtalmol"},{"key":"ref5","article-title":"A 50-year-old man with metamorphopsia and optic nerve swelling [Article in Japanese]","volume":"45","author":"Nakajima Y","year":"1993","unstructured":"Nakajima Y, Kitada T, Mizutani Y, et al.. A 50-year-old man with metamorphopsia and optic nerve swelling [Article in Japanese]. No To Shinkei. 1993, 45:485-92.","journal-title":"No To Shinkei"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-002-0573-9","article-title":"Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas","volume":"240","author":"Watanabe W","year":"2002","unstructured":"Watanabe W, Kuwabara R, Nakahara T, et al.. Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas. Graefes Arch Clin Exp Ophthalmol. 2002, 240:1033-5. 10.1007\/s00417-002-0573-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1997.tb00280.x","article-title":"Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy","volume":"96","author":"Caraceni A","year":"1997","unstructured":"Caraceni A, Martini C, Spatti G, Thomas A, Onofrj M. Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy. Acta Neurol Scand. 1997, 96:260-1. 10.1111\/j.1600-0404.1997.tb00280.x","journal-title":"Acta Neurol Scand"},{"key":"ref8","article-title":"Ocular changes with oxaliplatin","volume":"10","author":"O\u2019Dea D","year":"2006","unstructured":"O\u2019Dea D, Handy CM, Wexler A. Ocular changes with oxaliplatin. Clin J Oncol Nurs. 2006, 10:227-9.","journal-title":"Clin J Oncol Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000212087","article-title":"Carboplatin-induced bilateral papilledema: a case report","volume":"2","author":"Fischer N","year":"2009","unstructured":"Fischer N, Stuermer J, Rodic B, Pless M. Carboplatin-induced bilateral papilledema: a case report. Case Rep Oncol. 2009, 2:67-71. 10.1159\/000212087","journal-title":"Case Rep Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000357912","article-title":"Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma","volume":"7","author":"Lewis P","year":"2014","unstructured":"Lewis P, Waqar S, Yiannakis D, Raman V. Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma. Case Rep Oncol. 2014, 7:29-32. 10.1159\/000357912","journal-title":"Case Rep Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52975","article-title":"Blinding optic neuropathy associated with carboplatin therapy: a case report and literature review","volume":"16","author":"Shihadeh S","year":"2024","unstructured":"Shihadeh S, Patrick MM, Postma G, Trokthi B, Maitland C. Blinding optic neuropathy associated with carboplatin therapy: a case report and literature review. Cureus. 2024, 16:e52975. 10.7759\/cureus.52975","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v19i1.15448","article-title":"Bilateral optic neuropathy secondary to intravenous carboplatin therapy","volume":"19","author":"Maleki A","year":"2024","unstructured":"Maleki A, Lagrew MK, Slaney ED. Bilateral optic neuropathy secondary to intravenous carboplatin therapy. J Ophthalmic Vis Res. 2024, 19:133-6. 10.18502\/jovr.v19i1.15448","journal-title":"J Ophthalmic Vis Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060992","article-title":"Bilateral visual impairment following combination chemotherapy with carboplatin in patients with small cell lung cancer: a case report","volume":"60","author":"Kim J","year":"2024","unstructured":"Kim J, Lee J, Lee S, Kim K. Bilateral visual impairment following combination chemotherapy with carboplatin in patients with small cell lung cancer: a case report. Medicina (Kaunas). 2024, 60:992. 10.3390\/medicina60060992","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2392860","article-title":"Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports","author":"Hasik PN","year":"2024","unstructured":"Hasik PN, Thomas C, Hazarika M, Undela K. Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports. Expert Opin Drug Saf. 2024, 1-14. 10.1080\/14740338.2024.2392860","journal-title":"Expert Opin Drug Saf"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031476","article-title":"Reduced retinal function in the absence of Na(v)1.6","volume":"7","author":"Smith BJ","year":"2012","unstructured":"Smith BJ, C\u00f4t\u00e9 PD. Reduced retinal function in the absence of Na(v)1.6. PLoS One. 2012, 7:e31476. 10.1371\/journal.pone.0031476","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-005-7339-8","article-title":"Contribution to ischemic injury of rat optic nerves by intracellular sodium overload","volume":"110","author":"Dong CJ","year":"2005","unstructured":"Dong CJ, Hare WA. Contribution to ischemic injury of rat optic nerves by intracellular sodium overload. Doc Ophthalmol. 2005, 110:15-23. 10.1007\/s10633-005-7339-8","journal-title":"Doc Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275030-cisplatin-induced-toxic-optic-neuropathy-in-a-patient-with-hodgkins-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T06:38:46Z","timestamp":1726036726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275030-cisplatin-induced-toxic-optic-neuropathy-in-a-patient-with-hodgkins-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.69140","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}